Phase 2a study of EYP-001 in patients with Non-alcoholic-steatohepatitis
Phase of Trial: Phase II
Latest Information Update: 04 Jun 2018
At a glance
- Drugs EYP 001 (Primary)
- Indications Non-alcoholic steatohepatitis
- Focus Therapeutic Use
- 04 Jun 2018 According to an ENYO Pharma media release, completed a 40 million euro Series B financing from the US and European investors which will be used to support this trial.
- 05 Mar 2018 New trial record
- 27 Feb 2018 According to an ENYO Pharma media release, this trial is expected to begin in H2 2018.